A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01)
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Neonc Technologies, Inc.
Inhibrx Biosciences, Inc
Nurix Therapeutics, Inc.
AbbVie
The Netherlands Cancer Institute
Hoosier Cancer Research Network
Nektar Therapeutics
Wake Forest University Health Sciences
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Associació per a la Recerca Oncologica, Spain
Sunnybrook Health Sciences Centre
National Taiwan University Hospital